Zhou Qiyuan, Chen Tianji, Bozkanat Melike, Ibe Joyce Christina F, Christman John W, Raj J Usha, Zhou Guofei
Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois, United States of America; Children's Hospital University of Illinois, Chicago, Illinois, United States of America.
PLoS One. 2014 Dec 31;9(12):e116142. doi: 10.1371/journal.pone.0116142. eCollection 2014.
Replication deficient adenoviruses (Ad) vectors are common tools in gene therapy. Since Ad vectors are known to activate innate and adaptive immunity, we investigated whether intratracheal administration of Ad vectors alone is sufficient to induce lung injury and pulmonary fibrosis.
We instilled Ad viruses ranging from 107 to 1.625×109 ifu/mouse as well as the same volume of PBS and bleomycin. 14 and 21 days after administration, we collected bronchoalveolar lavage fluid (BALF) and mouse lung tissues. We measured the protein concentration, total and differential cell counts, and TGF-β1 production, performed Trichrome staining and Sircol assay, determined gene and protein levels of profibrotic cytokines, MMPs, and Wnt signaling proteins, and conducted TUNEL staining and co-immunofluorescence for GFP and α-SMA staining.
Instillation of high dose Ad vectors (1.625×109 ifu/mouse) into mouse lungs induced high levels of protein content, inflammatory cells, and TGF-β1 in BALF, comparable to those in bleomycin-instilled lungs. The collagen content and mRNA levels of Col1a1, Col1a2, PCNA, and α-SMA were also increased in the lungs. Instillation of both bleomycin and Ad vectors increased expression levels of TNFα and IL-1β but not IL-10. Instillation of bleomycin but not Ad increased the expression of IL-1α, IL-13 and IL-16. Treatment with bleomycin or Ad vectors increased expression levels of integrin α1, α5, and αv, MMP9, whereas treatment with bleomycin but not Ad vectors induced MMP2 expression levels. Both bleomycin and Ad vectors induced mRNA levels of Wnt2, 2b, 5b, and Lrp6. Intratracheal instillation of Ad viruses also induced DNA damages and Ad viral infection-mediated fibrosis is not limited to the infection sites.
Our results suggest that administration of Ad vectors induces an inflammatory response, lung injury, and pulmonary fibrosis in a dose dependent manner.
复制缺陷型腺病毒(Ad)载体是基因治疗中的常用工具。由于已知Ad载体可激活先天性和适应性免疫,我们研究了单纯气管内给予Ad载体是否足以诱导肺损伤和肺纤维化。
我们给小鼠气管内滴注10⁷至1.625×10⁹ifu/小鼠的Ad病毒以及相同体积的PBS和博来霉素。给药后14天和21天,我们收集支气管肺泡灌洗液(BALF)和小鼠肺组织。我们测量了蛋白质浓度、总细胞数和分类细胞数以及TGF-β1的产生,进行了三色染色和Sircol测定,测定了促纤维化细胞因子、基质金属蛋白酶(MMPs)和Wnt信号蛋白的基因和蛋白水平,并进行了TUNEL染色以及GFP和α-SMA染色的共免疫荧光检测。
向小鼠肺内滴注高剂量Ad载体(1.625×10⁹ifu/小鼠)可诱导BALF中高水平的蛋白质含量、炎性细胞和TGF-β1,与滴注博来霉素的肺组织相当。肺组织中胶原蛋白含量以及Col1a1、Col1a2、增殖细胞核抗原(PCNA)和α-SMA的mRNA水平也升高。同时滴注博来霉素和Ad载体可增加TNFα和IL-1β的表达水平,但不增加IL-10的表达水平。滴注博来霉素而非Ad可增加IL-1α、IL-13和IL-16的表达。用博来霉素或Ad载体处理可增加整合素α1、α5和αv、MMP9的表达水平,而用博来霉素而非Ad载体处理可诱导MMP2表达水平升高。博来霉素和Ad载体均可诱导Wnt2、2b、5b和低密度脂蛋白受体相关蛋白6(Lrp6)的mRNA水平。气管内滴注Ad病毒还可诱导DNA损伤,且Ad病毒感染介导的纤维化不限于感染部位。
我们的结果表明,给予Ad载体可剂量依赖性地诱导炎症反应、肺损伤和肺纤维化。